A combination of hepatitis B immunoglobulin (HBIG) and nucleos (t) ide analogues (NUCs)
is currently recommended as prophylaxis against the recurrence of hepatitis B virus (HBV) …

Since the early 1990's, hepatitis B immune globulin (HBIG) has been central to the
prevention of hepatitis B virus (HBV) recurrence after liver transplantation. When used in …

BACKGROUND & AIMS: We investigated the efficacy of entecavir, a cyclopentyl guanosine
nucleoside analogue, as monoprophylaxis in patients with chronic hepatitis B who received …

Mother-infant transmission of hepatitis B virus (HBV) accounts for up to 30% of worldwide
chronic infections. The mechanism and high-risk period of HBV transmission from mother to …

The progress in treatment against hepatitis B virus (HBV) has substantially improved the
outcome of all HBV‐infected patients. We systematically reviewed the existing data in the …

SUMMARY Dear Colleagues, Guidelines provide guidance to physicians in the diagnosis
and management of diseases as well as to official authorities in the process of approval and …

Like in the rest of the world, hepatitis B virus (HBV) infection is also a major health problem
in our country. Approximately 400 million are known to be chronically infected with HBV …

Background In this study, we retrospectively analyzed the recurrence of hepatitis B virus
(HBV) and hepatitis D virus (HDV) infection after liver transplantation for HBV and HBV+ …

The combination of hepatitis B immunoglobulin and potent nucleos (t) ide analogs after liver
transplantation is considered as the standard of care for prophylaxis against hepatitis B virus …

Background The aim of this study was to determine the long‐term efficacy of nucleos (t) ide
analog (NA) and low‐dose hepatitis B immunoglobulin (HBIG) combination treatment for …